Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CytoNiche logo — Pioneering 3D micro-organization engineering for advanced st...

CytoNiche

Pioneering 3D micro-organization engineering for advanced stem cell solutions, inspired by Tsinghua University's innovative achievements.

Founded 2018 51-200 employees Grant Total: $300.01M Biotechnology, Health Care +2

General Information

Company Name CytoNiche
Founded Year 2018
Employees 51-200
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with CytoNiche. To contact CytoNiche, visit cytoniche.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About CytoNiche

CytoNiche is a biotechnology startup that focuses on pioneering 3D micro-organization engineering for advanced stem cell solutions. Inspired by Tsinghua University's innovative achievements, the company specializes in harnessing 3D micro-organization engineering technology. Leveraging proprietary research, CytoNiche has introduced a suite of innovative products and services, including bespoke, large-scale, automated, and intelligent stem cell cultivation. These offerings encompass the amplification process, regenerative treatments with 3D stem cell micro-tissues, and high-throughput drug screening products using 3D cell models. Established in 2018, the company operates within the industries of biotechnology, health care, life sciences, and VR/AR. In its latest investment round, CytoNiche secured a $10.00K grant investment on 05 July 2023 from the BRICS-Singapore entrepreneurship competition.

Taxonomy: 3D micro-organization engineering, stem cell solutions, Tsinghua University, Huasheng Bio, cell culture, cell therapy, gene therapy, regenerative medicine, tissue engineering, research technology, regenerative treatments, drug screening, automated cultivation, intelligent stem cell

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $10.00K 1
BRICS-Singapore entrepreneurship competition
05 Jul 2023
Series B CNY300.00M 9
DT Capital Partners Gaorong Capital 3E Bioventures Capital
DT Capital Partners, Gaorong Capital +7
03 Mar 2022
Series A Undisclosed -
03 Sep 2020
Series A Undisclosed -
22 Aug 2019

CytoNiche Alternatives & Competitors

View All Alternatives
CytoNiche vs
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. United States

Transforming medicine through engineered cellular therapies that restore, regenerate, and repair tis...

Grant
21 employees
Biotechnology, Health Care
CytoNiche vs
Matrigen
Matrigen United States

Introducing Softwell®. It's coming to a lab near you.

2 employees
Biotechnology, Health Care
CytoNiche vs
PrimeCell Bioscience, a.s.
PrimeCell Bioscience, a.s. Czech Republic

Měníme klasické paradigma léčby

4 employees
Biotechnology, Health Care
View all alternatives

FAQ About CytoNiche

Pioneering 3D micro-organization engineering for advanced stem cell solutions, inspired by Tsinghua University's innovative achievements.
CytoNiche was founded in 2018.
CytoNiche operates in Biotechnology, Health Care, Life Sciences and VR/AR. Its work centres on 3D micro-organization engineering, stem cell solutions, Tsinghua University and Huasheng Bio.
CytoNiche has approximately 51-200 employees.
CytoNiche has completed 4 funding rounds, raising a total of $300.01M. The latest funding stage is Grant.
Top alternatives and competitors to CytoNiche include Angiocrine Bioscience, Inc., Matrigen, PrimeCell Bioscience, a.s., Aglaris Ltd Group, Akron Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CytoNiche and Angiocrine Bioscience, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CytoNiche, https://bouncewatch.com/company/cytoniche, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes